Improve the cardiovascular disease provention and management in China according to the evidence-based medicine principles

( views:, downloads: )
HU Da-yi()
Journal Title:
Volume 1, Issue 01, 2007
Key Word:


  • [1]Criqui MH.Mortality over a period of 10 years in patients with peripheral arterial disease.N Engl J Med,1992,326:381-386.
  • [2]Wilterdink JI,Easton JD.Vascular event rates in patients with atherosclerotic cerebrovascular disease.Arch Neuro,1992,49:857-863.
  • [3]Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Aduhs.Executive summary of the third report of the national cholesterol education program(NCEP)expert panel on detection,evaluation,and treatment of high blood cholesterol in adults(adult treatment panel Ⅲ).JAMA,2001,285:2486-2497.
  • [4]Critchley J,Liu J,Zhao D,et al.Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999.Circulation,2004,110:1236-1244.
  • [5]Ounpuu S,Negassa A,Yusuf S.INTER-HEART:a global study of risk factors for acute myocardial infarction.Am Heart J,2001,141:711-721.
  • [6]Centers for Disease Control(CDC).1986 surgeon general's report:the health consequences of involuntary smoking.Rep,1986,35:769-770.
  • [7]Murabito JM,Evans JC,Larson MG,et al.Prognosis after the onset of coronary heart disease:an investigation of differences in outcome between the sexes according to initial coronary disease presentation.Circulation,1993,88:2548-2555.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615